Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hope

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Nature Communications|April 7, 2023
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaquesLaura Solforosi, Lea M M Costes, Jeroen T B M Tolboom, et al.
BMJ Open|December 10, 2023
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UKTimothy Simon Walsh, Leanne M Aitken, Cathrine A McKenzie, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluationTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Nature|December 14, 2023
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaquesKatherine McMahan, Frank Wegmann, Malika Aid, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Nature|November 18, 2021
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccineMakda S Gebre, Susanne Rauch, Nicole Roth, et al.
Nature Communications|May 19, 2022
Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cellsDeepak Bhere, Sung Hugh Choi, Pim van de Donk, et al.
Cell|April 15, 2022
Vaccine protection against the SARS-CoV-2 Omicron variant in macaquesAbishek Chandrashekar, Jingyou Yu, Katherine McMahan, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in MacaquesAbishek Chandrashekar, Jingyou Yu, Katherine McMahan, et al.
Wellcome Open Research|May 28, 2021
-------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--Leila Reyes, Manuel A Sanchez-Garcia, Tyler Morrison, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Nature Communications|April 7, 2023
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaquesLaura Solforosi, Lea M M Costes, Jeroen T B M Tolboom, et al.
BMJ Open|December 10, 2023
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UKTimothy Simon Walsh, Leanne M Aitken, Cathrine A McKenzie, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluationTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Nature|December 14, 2023
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaquesKatherine McMahan, Frank Wegmann, Malika Aid, et al.
JAMA|May 19, 2025
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical TrialTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.
Nature|November 18, 2021
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccineMakda S Gebre, Susanne Rauch, Nicole Roth, et al.
Nature Communications|May 19, 2022
Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cellsDeepak Bhere, Sung Hugh Choi, Pim van de Donk, et al.
Cell|April 15, 2022
Vaccine protection against the SARS-CoV-2 Omicron variant in macaquesAbishek Chandrashekar, Jingyou Yu, Katherine McMahan, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in MacaquesAbishek Chandrashekar, Jingyou Yu, Katherine McMahan, et al.
Wellcome Open Research|May 28, 2021
-------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--Leila Reyes, Manuel A Sanchez-Garcia, Tyler Morrison, et al.
Pageof 6